A B S T R A C T Recent studies from several laboratories have documented the presence of fragments of parathyroid hormone in blood or peripheral tissues or in both. Inasmuch as amino-terminal fragments are known to be biologically active, it has been suggested that fragments, rather than the intact polypeptide of 84 amino acids, might be the active molecular species in tissue fluids.
INTRODUCTION
Parathyroid hormone (PTH)1 is an 84-amino-acid, single-chain polypeptide (1-3) with virtually full biological activity residing within the amino-terminal 34 residues of the molecule (4) (5) (6) . Immunoassay studies of the circulating forms of PTH in man (7) (8) (9) (10) (11) (12) (13) (14) and cow (8) have demonstrated heterogeneity resulting from the presence of hormonal fragments in the circulation. The predominant circulating entity seems to be biologically inactive, consisting of the middle and carboxyl-terminal portions (10, 12, 13, 15) of the hormone. It was reported that an amino-terminal fragment with the necessary requirements for biological activity exists in the circulation of man (16); a similar or identical fragment is apparently capable of being generated in peripheral tissues (15, (17) (18) (19) . These findings have led to the suggestion by several groups (15, 18, 20) that the amino-terminal fragment(s), rather than the glandular intact 84-amino-acid form of the hormone, might be the form(s) of the molecule responsible for the hormonespecific effects on target tissues. The purpose of the studies described here was to determine in systems in vitro whether biological activity (stimulation of adenylyl cyclase) could be observed in the absence of cleavage of the native hormone to an independent active fragment.
METHODS
Hormones. The 1-84 bPTH I [about 3,000 Medical Research Council (MRC) U/mg] was extracted from bovine parathyroid glands and purified as previously described (1) . Native bPTH-(1-84), used as a standard in the adenylyl cyclase assay for potency determination, was MRC Research Standard, Lot MRC 72/286 (National Institute for Medical Research, Mill Hill, London, England). bPTH-(1-34) was synthesized as previously described (4) .
[3H] bPTH- , [14C] bPTH-(1-84), and [ES] bPTH- were isolated from bovine parathyroid gland slices incubated with ['H]leucine, "4C-labeled amino-acid mixtures, and [S]methionine, respectively. Details of the incubation, extraction, and separation methods have been described (21) . To prevent oxidation of the hormones, polyacrylamide gels used in the purification procedure were pre-electrophoresed and aged in water for 48 h to permit outward diffusion of ammonium persulfate. bPTH-(1-84) and bPTH- were iodinated with either 'I or 'I by the method of Hunter and Greenwood (22) , employing Quso G32 (Philadelphia Quartz Co., Philadelphia, Penn.) for purification followed by gel filtration on Bio-Gel P-100 (Bio-Rad Laboratories, Richmond, Calif.). The specific activity of 5I-bPTH-(1-84) was 300 ACi/g.
Membranes. Kidneys were obtained from male SpragueDawley rats, 150-200 g, from calves 7-10 days old, and from mongrel dogs, 20-27 kg, and highly purified renal cortical membranes were prepared by the method of Marx et al. (23) . The renal cortex was dissected free and homogenized at 4VC in a 30%o (vol/vol) buffer solution of 0.25 M sucrose, 0.01 M Tris, pH 7.5, and 0.001 M Na2EDTA. The homogenized tissue was then diluted 1: 1 with the buffer solution and spun in a Sorvall RC-2B ultracentrifuge (DuPont Instruments, Sorvall Operations, Newtown, Conn.) until the rotor (SS-34) speed reached 4,500 rpm (2,200 g ). The supernatant fluid was collected, and the centrifugation was repeated. The supernate of this second spin was then centrifuged at 4,500 rpm for 15 min, and the upper portion of the resulting double-layered pellet was resuspended in the previously described buffer solution, rehomogenized, and recentrifuged at 4,500 rpm for 15 min. The resulting pellet was resuspended in a small volume of the buffer solution and layered onto continuous 11-ml linear gradients of 32%o-42%o (wt/wt) sucrose in 0.01 M Tris, pH 7.5, 0.001 M Na1
EDTA. Gradients were centrifuged for 60 min at 25,000 rpm in the SW41 rotor of a Beckman L2-65B ultracentrifuge at 40C (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). After centrifugation, two major bands of turbidity in addition to a pellet were readily identified with preparations from each species. The (23) , enriched in Na/K-ATPase and adenylyl cyclase activity, and decreased in specific activity of marker enzymes for endoplasmic reticulum and brush border (23 was added in 50 ul of 8 M guanidine to the incubation mixtures containing 3H radioactivity to mark the elution position of intact hormone, and 1"I-labeled bPTH-(l-84), 'Ilabeled bPTH-(1-34), and Na'31I were added in 50 pAl 20% acetone-i % acetic acid to the incubation mixtures containing "2I radioactivity to mark the elution positions of intact hormone, active fragment, and the salt peak. The columns used for 3H and 'S radioactivity were subsequently calibrated with "NI-labeled bPTH- and Na'I. The A 20-Aul aliquot of unlabeled native bPTH-(1-84), incubated with membranes as described above, was added to 500 p1 of 8-M guanidine containing 'I-labeled bPTH-(1-84), 1I-labeled bPTH-(1-34), and Na1"I as internal mark-ers. The latter guanidine mixture was then immediately chromatographed by gel filtration on a 1.2 X 70-cm column of Bio-Gel P-100 at 4°C. The column was eluted with a buffer consisting of 0.05 M barbital (pH 8.5), 0.01 M Na2EDTA, 0.01%o merthiolate, and 2%o (vol/vol) human plasma, and 0.9-ml fractions were collected and assayed for "I radioactivity in a gamma-well spectrometer (Packard Instrument Co.). The fractions (0.1-0.3-ml aliquots in duplicate of each fraction) were then analyzed for PTH by radioimmunoassay with l"I-labeled bPTH and GP-1 antiserum.
Analysis of hormonal form bound to membranes. To assess the nature of the hormone bound to the membrane, 48 ,ug of bPTH-(1-84) (0.5 ,uM) was incubated for 10 min at 22'C in a total volume of 10 ml containing 5.0 mg canine membrane protein and the solution described in Assay of adenylyl cyclase activity but without [a-'P]ATP, i.e., the usual incubation mixture of 0.5 uM bPTH-(1-84) was increased exactly 100-fold. Simultaneously, 0.5 ,M of the same preparation of bPTH-(1-84) was incubated with a 50-,g~g aliquot of the same membrane preparation for 10 min at 22'C in a total volume of 100 jul containing [aSP]j-ATP and assayed for adenylyl cyclase activity to determine the initial biological activity of the hormone. The largescale incubation was stopped after 10 min by immediately chilling the incubation mixture to 4°C and centrifuging at 2,200 g for 15 min. The supernate was then discarded, and the pellet was resuspended in 10 ml of 0.05 M Tris-HCl buffer, pH 7.4, and recentrifuged at 2,200 g for 15 min. The supernate was then removed, and the pellet containing bound hormone or fragment or both was dissolved in either 1 ml of 8 M guanidine or in 1 ml of 8 M urea.
50 ,ul of each pellet was then removed and appropriately diluted and radioimmunoassayed for PTH, with bPTH-(1-84) as a standard and GP-1 antiserum. An 0.2-ml aliquot of the pellet dissolved in 8 M urea [to which was added "311-labeled bPTH-(1-84) and 'I-labeled bPTH- 4VC. The resulting samples were counted for radioactivity and analyzed (0.001-0.002-ml aliquots, in duplicate, of each sample) for PTH and fragments by "N" and "C" radioimmunoassays as discussed below. An 0.5-ml aliquot of the pellet suspended in guanidine, to which were added 'Ilabeled-bPTH-(1-84), 1ZI-labeled-bPTH-(1-34), and Na"5I as markers, was chromatographed by gel filtration on BioGel P-100 as described in Incubation of hormone with membranes and analysis by gel chromatography. Fractions (0.002-0.015-ml aliquots, in duplicate, of each fraction) were then radioimmunoassayed for PTH and fragments, employing N and C assays. NH2-and COOH-terminal specific radioimmunoassays (N and C assays) used in these studies have previously been described (10) . In brief, aliquots of GP-1 antiserum were either preabsorbed with the natural fragment 53-84 and were thus incapable of recognizing the COOH-region of bPTH-(1-84) (N assay) or were preabsorbed with the synthetic fragment bPTH-(1-34) and were thus incapable of recognizing the NH2-region of bPTH-(1-84) (C assay). These modified antisera, used for measuring samples obtained from gel filtration and gel electrophoresis, were also used to establish appropriate standard curves with bPTH-(1-84) as standard. A 1.0-ml solution of the pellet in 8 M guanidine [to which were added "31I-labeled bPTH-(1-84), 'I-labeled bPTH-(1-34), and NaiI as markers] was chromatographed by gel filtration on a 1.2 X 70-cm column of BioGel P-30 and eluted with 0.1 M ammonium acetate, pH-6.3, collecting 0.9-ml fractions. The fractions containing the intact hormone peak and the fractions containing the activefragment peak (as judged from the elution patterns of the marker hormone and marker fragment, respectively) were each pooled separately and lyophilized. Each pool was then dissolved in 50 ,l of a solution of 2% BSA-0.0005 N acetic acid, and serial 1: 3 dilutions were made. 10 Al, in duplicate, of the three highest concentrations of each pool was then assayed for adenylyl cyclase activity.
Assay of adenylyl cyclase activity. Adenylyl cyclase activity was assayed at 220 or 37°C after 10 min, unless otherwise specified, by a modification (24) of a previously described method (25) . The incubation mixture contained, in a 100-,ul volume, 50 mM Tris-HCl, pH 7.4; 0.84 mM ATP; 0.8-2.0 X 10' cpm of [a-'P]ATP (New England Nuclear Corp., Boston, Mass.); 9 mM theophylline; 4 After ['H]bPTH-(1-84) was incubated with active canine renal cortical membranes for 10 min at 220C, more than 95% of the 3H radioactivity was precipitable with 15% trichloroacetic acid. Analysis by electrophoresis on polyacrylamide gels revealed only a single peak of radioactivity, containing 65% of the added counts, that comigrated with the [`C]bPTH-(1-84) marker (Fig. 2A) ; less than 3% of the added counts overlapped into the region corresponding to the migration position of bPTH-(1-34), and no peak appeared in this region of the gel. Furthermore, these results were the same as Analysis by gel filtration in 6 M guanidine hydrochloride of a mixture of 'I-labeled bPTH-(1-84) and active canine membranes incubated for 10 min at 220C also revealed only a single peak of radioactivity coeluting with the 'I-labeled bPTH-(1-84) marker (Fig. 3A) . The pattern of eluted radioactivity was essentially indistinguishable from that obtained after incubating the hormone with heat-inactivated membranes (Fig. 3B) . Although more than 83% of the 'I-radioactivity added to the membranes was recovered in the column eluate, less than 0.8% (less than 3 pg) was recovered in the eluate corresponding to the elution position of bPTH-(1-34).
Metabolism and biological activity of unlabeled PTH. When unlabeled native bPTH-(1-84), 0.5 uM, was incubated with active canine renal membranes for 10 min at 220C and a 96-ng aliquot was then analyzed by electrophoresis on polyacrylamide gels and radioimmunoassay, only a single peak of immunoreactive material was seen, comprising 47% of the immunoreactivity added and comigrating with the ['I]-labeled-bPTH-(1-84) marker (Fig. 4A) . No immunoreactive peak was seen comigrating with the fragment marker, and less than 3% of the immunoreactivity eluted in this region. This was identical with the electrophoretic profile obtained after incubation with heat-inactivated membranes (Fig. 4A) .
When another 96-ng aliquot of an identical solution of unlabeled bPTH-(1-84) and active canine mem- Fig. 2A) on polyacrylamide gels at pH 4.4, and by chromatography (Fig. 2B) on Bio-Gel A-0.5m with 6 M guanidine HCl-0.1 M ammonium acetate-lSo (vol/vol) human plasma, pH 6.5, as eluting buffer. For electrophoresis ( Fig. 2A) , [ '4C]bPTH-(1-84) was added to the gels to serve as an internal marker for intact hormone. The arrow ( Fig. 2A) represents the migration position of 'I-labeled bPTH-(1-34) run in parallel gels. "Control" (Fig. 2A) represents the pattern obtained after incubation of ['H]bPTH-(1-84) with heat-inactivated membranes. For chromatography (Fig. 2B) , ["5S]bPTH- was added to the column to serve as an internal marker for intact hormone. The column was subsequently calibrated with "'I-labeled bPTH- and Na"'I to mark the elution positions of active fragment and salt peak, respectively. V. represents the void volume. A pattern of radioactivity identical with Details of the incubation, electrophoresis, and chromatography are described in the text.
branes, incubated simultaneously with the previous mixture, was analyzed by gel filtration on Bio-Gel P-100 and by radioimmunoassay, the immunoreactive material recovered (65% of the added hormone) coeluted with the 'I-labeled-bPTH-(1-84) marker (Fig. 4B) . No immunoreactive peak was seen coeluting with the fragment marker, and no more than 2% of the added hormone could have eluted here and escaped detection by the radioimmunoassay. Furthermore, the chromato-graphic profile was identical with the pattern obtained (Fig. not shown) after incubation with heat-inactivated membranes.
The adenylyl cyclase activity of the remainder of the incubation mixtures from which aliquots had been removed for electrophoresis and chromatography is demonstrated in bars A and C in the inset in Fig. 4 . There was simultaneous determination of the activity of incubation mixtures containing either active membranes but no active hormone (bar B), or active membranes with active hormone from which no aliquots had been removed (bar D) . These experiments demonstrated the presence of biological activity in the membranes at 220C and the adequacy of the heat-inactivated membranes as a control. More important, they demonstrated the pres-ACTIVE MEMBRANES FRACTION NUMBER FIGURE 4 Analysis of unlabeled immunoreactive bPTH-(1-84), after incubation with canine renal cortical membranes for 10 min at 22°C, by electrophoresis (Fig. 4A) on polyacrylamide gels at pH 4.4, by chromatography (Fig.  4B) on Bio-Gel P-100, and by bioassay (inset). For electrophoresis (Fig. 4A) , 'I-labeled bPTH-(1-84) ('II pattern of migration shown) and 'I-labeled bPTH-(1-34) (migration position represented by the arrow) were added to the gels to serve as internal markers for intact hormone and active fragment, respectively. "Control" represents the electrophoretic profile obtained after incubation of unlabeled bPTH-(1-84) with heat-inactivated membranes. For chromatography (Fig. 4B) , "SI-labeled bPTH-(1-84), 'Ilabeled bPTH-(1-34), and NaizI were added to the column to serve as internal markers. V. represents the void volume. An identical elution pattern was obtained after incubation of unlabeled bPTH-(1-84) with heat-inactivated membranes. Details of the incubation, electrophoresis, chromatography, and immunoassays with nonadsorbed GP-1 antiserum are described in the text. Assay of adenylyl cyclase activity of samples simultaneously analyzed by electrophoresis and chromatography is depicted in the inset. "Activity" Fig. 5A) or by gel filtration on columns of Bio-Gel P-100 (Fig. 5B) . Hormone in each gel slice (Fig. 5A) or each column fraction (Fig. 5B ) was immunoassayed with separate N and C assays as described in the text. "'I-labeled or 'I-labeled bPTH-(1-84), 2';I-labeled bPTH-(1-34), and NaflI (for gel filtration only) were added before electrophoresis or chromatography to serve as internal markers. V. represents the void volume of the column, and DL the detection limit of the immunoassay. Details of the experimental procedures are described in the Methods section.
ence of biological activity in the native PTH simultaneously subjected to analysis by electrophoresis and chromatography.
Metabolism and biological activity of membrane-bound PTH. To ascertain that no fragmentation of the hormone was being detected in the incubation mixture because only a small fraction of the total hormone, (i.e., that fraction bound to membrane receptors) was being metabolized, the experimental design was modified, as described in Methods, to permit chemical and biological characterization of the hormone bound to membrane.
The unlabeled hormone bound to the active canine membrane represented 7.3% (mean of triplicate determinations) of the unlabeled bPTH-(1-84) added to the incubation mixture, as determined by radioimmunoassay.
When analyzed by polyacrylamide gel electrophoresis and radioimmunoassay employing region-specific N and C assays, the hormone bound to the membrane migrated as a single peak, comigrating with the 'I-labeled bPTH-(1-84) intact hormone marker and representing 89% > of the added immunoreactivity (Fig. 5A) T M E, min FIGURE 7 Generation of cAMP in the absence of added hormone ("basal") in the presence of 0.02 /AM (Fig. 7A) or 0.5 /AM (Fig. 7B) bPTH-(1-34) , and in the presence of 0.02 jM (Fig. 7A) or 0.5 juM (Fig. 7B) bPTH-(1-84).
Canine (Fig. 7A) or rat (Fig. 7B ) renal cortical membranes (0.5 mg/ml) were incubated for adenylyl cyclase activity at 22°C with the appropriate concentrations of hormones in a final incubation volume of 2.3 ml. Generation of cAMP was followed by removing, at the times indicated, 100-jul aliquots and determining the [3P] cAMP formed from [a-"P]ATP as described in the text. The remainder of the experimental conditions is given in Methods.
When analyzed by gel filtration and radioimmunoassay employing N and C assays, the membrane-bound hormone coeluted with the MI-labeled bPTH-(1-84) intact hormone marker (62% of the added immunoreactivity was recovered in the intact hormone peak) (Fig.  SB) . No immunoreactivity coeluted with the 'I-labeled bPTH-(1-34) fragment marker, and no more than 3% of the NH2-terminal immunoreactivity in the pellet could have eluted in the 10 fractions comprising the hormone fragment elution position and escaped detection by radioimmunoassay. Consequently, the maximum NH2-terminal immunoreactivity bound to the membrane that could have escaped detection by this method is 0.2% of the hormone added to the incubation mixture.
To ascertain whether the minute amounts of immunoreactivity that might have escaped detection by the methods employed were indeed of biological significance, the membrane-bound hormone was again fractionated by gel filtration. The eluate fractions corresponding to (a) the intact hormone and (b) any possible hormone fragments smaller than the intact hormone but larger than 'I were pooled separately (Fig. 6 ). Each fraction was tested for biological activity in canine membranes in three dilutions (Fig. 6 ). Only fraction a demonstrated the capacity to stimulate adenylyl cyclase. Fraction b exhibited no stimulation of adenylyl cyclase activity above basal.
Kinetics of hormone-stimulated adenylyl cyclase. The kinetics of hormone-stimulated adenylyl cyclase were studied to assess the possible relationship, with regard to biological activity, between bPTH-(1-84) and an active amino-terminal fragment, as precursor and product, respectively. The generation of cyclic 3',5'-adenosine monophosphate (cAMP) with time was determined in canine and rat renal cortical membranes at 220C in the absence of hormone and in the presence of equimolar submaximal concentrations of bPTH-(1-84) and bPTH-(1-34), 2 X 10' M in the canine and 10' M in the rat membranes, respectively (Fig. 7) . The (Fig. 2) . Only active rat membranes produced significant degradation of bPTH-(1-84) (Figs. 8 and 9) .
The adenylyl cyclase activities of the three types of membranes in the presence of increasing concentrations of bPTH-(1-84) were then compared (Fig. 10) . Halfmaximal activation of bovine and canine adenylyl cyclase was achieved at concentrations of 10' M and 1.5 X 10' bPTH-(1-84), respectively. Adenylyl cyclase prepared from rat membranes was much less sensitive, requiring 5 X 10' M bPTH-(1-84) for half-maximal activation.
DISCUSSION
Previous demonstration that PTH, added as an intact peptide of 84 amino acids directly to suspensions of renal cortical membranes, stimulated adenylyl cyclase (27) apparently established that the intact polypeptide was indeed active without the requirement for metabolic alteration before receptor interaction. Evidence has accumulated from multiple laboratories, however, concerning generation of hormonal fragments (7) (8) (9) (10) (11) (12) (13) (14) , of which some, on the basis of the region of the hormone sequence they represented and knowledge of structure-activity relationships (5), must be considered as potentially biologically active (5) . The exact tissue site of proteolysis is unclear (8, 12, 13, 15, 17, 18, 20) ; however, in addition to possible cleavages within the parathyroid glands or in peripheral tissues generally, cleavage in sites adjacent to receptors in target organs (19, 28, 29) must be considered. This has led several laboratories to the logical conclusion that, if proteolytic enzymes were active in renal cortical membrane suspensions used for assays in vitro, cleavage of the intact hormone into active fragments might occur, and hence the fragments, rather than intact hormone, might be the active species (15, 18, 20) . The present studies were therefore undertaken to examine critically whether cleavage of hormone into fragments occurred on the renal cortical membrane suspensions where adenylyl cyclase, the marker of biological activity, is stimulated in vitro.
Two labeled preparations of hormone, biosynthetic, internally labeled [8H]bPTH-(1-84) and 'I-labeled bPTH-(1-84), were studied in addition to preparations of native biologically active unlabeled bPTH-(1-84).
Metabolism of these hormones in renal membranes was studied at two temperatures, 220 and 370C, in preparations of kidney tissue from three species, rat, dog, and cow. The integrity of the hormone after incubation with renal membranes was assessed on the basis of both charge and size by electrophoresis and gel filtration with and without added denaturing solvents. The analytic systems used achieve excellent resolution of intact hormone from hormonal fragments (Fig. 5) . No (Fig. 9A ), active rat (Fig. 9B ), or inactive rat (Fig. 9C ) renal cortical membranes for 10 min at 37°C.
[3S]bPTH-(1-84) was added to the columns just before chromatography to serve as a marker for intact hormone.
The columns were subsequently calibrated with "zI-labeled bPTH-(1-34) and NaI to mark the elution positions of active fragment and salt peak, respectively. could be demonstrated during an interval of membrane exposure associated with strong adenylyl cyclase stimulation in bovine and canine membranes. Furthermore, when stimulation of adenylyl cyclase by bPTH- and bPTH-(1-34), respectively, was studied as a function of time, no significant difference was seen in the time-course of the stimulation produced; that is, there was no significant lag before the onset of stimulation by bPTH-(1-84) in comparison with bPTH-(1-34) in either dog or rat membranes, and the rates of formation of cAMP were identical over the 20-min interval for both intact hormone and active amino-terminal fragment in both species. Consequently, the kinetics of hormone-stimulated adenylyl cyclase activity do not support the concept that a precursor-product relationship between bPTH-(1-84) and amino-terminal fragments is necessary for adenylyl cyclase stimulation. When the issue of hormonal degradation was examined at 37°C with the three membrane preparations employed, only purified membranes from the rat showed any degradative activity. This is consistent with previous reports of degradation of bPTH by rat microsomal fractions of rat homogenates (30) (31) (32) . When the degradation of bPTH is analyzed, however, in conjunction with the dose-response curves, it appears that this proteolysis, rather than being important in the activation of PTH, may contribute to the decreased sensitivity of the adenylyl cyclase assay performed with rat kidney membranes. This concept is supported by the finding of identical kinetics of activation of adenylyl cyclase by both the hormone and active fragment, even in rat membranes.
Not only are these overall findings consistent with the thesis that proteolytic modification is not required before stimulation of adenylyl cyclase by intact PTH, but the results may also be of practical interest in the design of bioassays in vitro for the hormone. Thus, detailed features of structure-activity relationships such as receptor-binding requirements (and inhibition of binding by antagonists and partial agonists [24] ), as well as analysis of cofactors and essential steps in hormone action in vitro, may be made more easily in membrane systems from dog and cow, which exhibit a greater sensitivity and a lesser degree of contamination with degradative enzymes than do the previously described and widely used membrane preparations from rats.
In considering the major issue addressed in these studies, namely, whether intact hormone does act on receptors in bone and kidney in vivo without prior cleavage, several potential problems must (33) , in view of its high specific activity, it provides the considerable advantage of ease of detection of small concentrations of generated fragments. Furthermore, 'I-labeled PTH, when injected into dogs, is cleaved in a precise fashion that, by gel filtration, is indistinguishable from the cleavage pattern generated in vivo when unlabeled biologically active hormone is used in identical studies (15) . Hence, we can state that the very cleavage process seen in vivo that has led us to investigate whether cleavage precedes hormone action can be detected with 'I-labeled PTH.
Therefore, it seems appropriate to use the 'I-labeled PTH as a probe for cleavage by renal cell membrane suspensions. Because the issue of cleavage before action is so critical in many aspects of PTH physiology, it seemed essential to use other preparations of hormone known to be biologically active. The criterion of known biological activity could be met with the tritiated hormone preparations. Incorporation of tritiated amino acids per se does not cause loss of activity, and the preparation after internal labeling was purified with special precautions to ensure against loss of activity during gel electrophoresis. The potency of the tritiated hormone preparation was directly determined by bioassay ( Fig. 1) , which confirmed that it was biologically active. As a final precaution, and to further increase the confidence limits for detection of cleavages, we used unlabeled hormone, previously demonstrated to possess full specific biological activity, to provide an independent third approach to study the cleavage problem by immunological techniques during fractionation studies after exposure of the hormone to membranes.
With With regard to specificity, structure-function studies with bPTH and numerous analogues have demonstrated, in general, good correlation between the activity of the analogues in vitro in the renal adenylyl cyclase assay in the rat, and in vivo in various assays including hypercalcemia in the chick (believed to reflect primarily action on bone) (5) and urinary excretion of phosphate and cAMP in the rat (34, 35) . There are residual questions, however, about binding affinity. In particular, the assay in vitro appears to be much more influenced by alterations in the amino-terminal residue of PTH (position 1) than does the assay in vivo (35) . The discrepancy between results in vivo and in vitro exhibited by analogues with alterations at position 1 are not explicable merely by invoking different structural requirements for bone receptors and renal receptors, because these forms of the hormone are equipotent with the bovine 1-84 standard when assayed for urinary cAMP (34) or phosphate excretion (35) in vivo in rats. Furthermore, an extreme divergence is noted between doseresponses of intact hormone in vitro (even in the more sensitive dog and cow membrane system) (100 nM) and those detected in vivo (10 pM) (35) .
One could explain some of these discrepancies in results of bioassays in vivo and in vitro by the view that much of the binding in vitro represents the effect of high-capacity, low-affinity binding sites (requiring hormone concentrations of 100 nM) that differ in binding requirements from those of the presumed high-affinity receptors coupled to physiological responses, such as phosphaturia or calcium mobilization in vivo (stimulated at concentrations of 10 pM). Overall, however, the abundant accumulated evidence that generation of cAMP is a critical intermediate in expression of PTH action in vivo (34) and the good correspondence in structureactivity studies with hormone analogues between the in vitro adenylyl cyclase assay and in vivo assays suggest that the in vitro system employed here is an appropriate test system. Hence, despite the reservations concerning the adequacy of the in vitro assay as a model for hormone action in vivo, the present results do provide considerable data, involving multiple hormone preparations, membrane systems, and analytical methods, hitherto not available, that cleavage of the intact hormone seems not to be required for expression of activity, at least in renal receptors.
These observations in vitro should not be considered to disagree with findings and conclusions of others or ourselves concerning the existence of fragments in the circulation or the peripheral metabolism, or both, of hormone. Although the present studies support the concept that cleavage of PTH is not required before its action, they do not diminish the potential physiological significance of the sensitive and specific metabolic pathway of the hormone detected in recent studies (15) (16) (17) (18) , or the importance of circulating fragments detected by still other groups (11) (12) (13) . Thus, it may be proved ultimately that metabolism of PTH results in production of fragments that are biologically significant with a spectrum or duration of activity that differs from those of the intact hormone, even though intact hormone itself does act directly on receptors. Alternatively, the degradation of hormone may play a physiologically important catabolic function, namely, acceleration of the removal of biologically active hormone from blood. Peripheral metabolism could prove to be an important control point for the overall regulation of the action of PTH. Such issues can only be resolved with further studies now in progress in several laboratories.
